Independent Advisor Alliance Adma Biologics, Inc. Transaction History

Independent Advisor Alliance

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 01, 2021
BUY
$1.13 - $1.65 $11,518 - $16,818
10,193 New
10,193 $12,000
Q1 2021

May 14, 2021
SELL
$1.67 - $2.95 $17,022 - $30,069
-10,193 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$1.8 - $2.56 $18,347 - $26,094
10,193 New
10,193 $20,000

Others Institutions Holding ADMA

# of Institutions
317
Shares Held
189M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.23B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Independent Advisor Alliance Portfolio

Follow Independent Advisor Alliance and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Advisor Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Independent Advisor Alliance with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email